FCRL5 Overview
Molecule Name
Fc receptor-like protein 5
Synonyms
BXMAS1, CD307, CD307e, FCRH5, IRTA2, PRO820
Drug Development Progress
Drugs in Clinical Trials3
Approved Drugs0
Highest Development StagePhase 2 Clinical
Target Synonym
Fc Receptor-Like 5，CD307e Antigen，PRO820，CD307e，Fc Receptor Like 5，FcR-like protein 5，BXMAS1，Fc receptor homolog 5，FcRH5，Immune receptor translocation-associated protein 2，CD_antigen: CD307e，IRTA2，Immunoglobulin Superfamily Receptor Translocation Associated 2 (IRTA2)
Background
May be involved in B-cell development and differentiation in peripheral lymphoid organs and may be useful markers of B-cell stages. May have an immunoregulatory role in marginal zone B-cells.
FCRL5 Product List
You Have Viewed 0 Of 0 Results
Clinical Drug Information
| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| anti-BCMA/FcRL5 CAR T cell therapy (Xuzhou Medical University) | Phase 2 Clinical | Xuzhou Medical University (Xzmu) | Multiple Myeloma | Details | |
| Anti-FcRL5 CAR-T Cell Therapy(Xuzhou Medical University) | Phase 2 Clinical | Xuzhou Medical University (Xzmu) | Multiple Myeloma | Details | |
| Cevostamab | RG-6160; BFCR-4350A; RO-7187797 | Phase 2 Clinical | Genentech Inc | Lupus Erythematosus, Systemic; Multiple Myeloma | Details |